Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations (Q40795919)

23 September 2017

Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations (English)

1 reference

23 September 2017

Ronchetti D

1

1 reference

23 September 2017

Greco A

2

1 reference

23 September 2017

Compasso S

3

1 reference

23 September 2017

Colombo G

4

1 reference

23 September 2017

Dell'Era P

5

1 reference

23 September 2017

Otsuki T

6

1 reference

23 September 2017

Lombardi L

7

1 reference

23 September 2017

Neri A

8

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

23 September 2017

1 reference

23 September 2017

20

1 reference

23 September 2017

3553-3562

1 reference

23 September 2017

27

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1204465

23 September 2017

0 references

cites work

High-efficiency transformation of mammalian cells by plasmid DNA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204465

Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204465

Fibroblast growth factor receptor 3 is a negative regulator of bone growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204465

The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204465

Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204465

FGF signaling activates STAT1 and p21 and inhibits the estrogen response and proliferation of MCF-7 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204465

Fibroblast growth factor receptors (FGFRs) localize in different cellular compartments. A splice variant of FGFR-3 localizes to the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204465

Signal transduction pathway of human fibroblast growth factor receptor 3. Identification of a novel 66-kDa phosphoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204465

Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204465

Activation of FGF receptors by mutations in the transmembrane domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204465

Pathogenesis of Burkitt lymphoma: expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204465

Fibroblast-growth-factor receptor mutations in human skeletal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204465

Establishment of five human myeloma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204465

Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204465

Effect of transmembrane and kinase domain mutations on fibroblast growth factor receptor 3 chimera signaling in PC12 cells. A model for the control of receptor tyrosine kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204465

Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204465

FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204465

The choice between alternative IIIb and IIIc exons of the FGFR-3 gene is not strictly tissue-specific

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204465

WHSC1, a 90 kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf-Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204465

A sequence motif in the transmembrane region of growth factor receptors with tyrosine kinase activity mediates dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204465

Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204465

A gene encoding a fibroblast growth factor receptor isolated from the Huntington disease gene region of human chromosome 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204465

Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204465

FGFR activation in skeletal disorders: too much of a good thing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204465

Enhanced signaling and morphological transformation by a membrane-localized derivative of the fibroblast growth factor receptor 3 kinase domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204465

Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204465

7 January 2021

Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondrocyte proliferation in thanatophoric dysplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204465

7 January 2021

Hepatic canalicular membrane 4: expression of the multidrug resistance genes in the liver.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204465

7 January 2021

In vitro excess ammonia production in human myeloma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204465

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1204465

1 reference

Dimensions Publication ID

23 September 2017

0 references

1 reference